Skin condition
Cradle cap, or pityriasis capitis, is a form of childhood seborrheic dermatitis. It is a very common, non-inflammatory, chronic but self-limiting skin condition, which usually appears between the third week and the first months of life, with a peak incidence around 3 months. The precise causes are not known, but the role of maternal hormones is hypothesized, which excessively stimulate the sebaceous glands of the newborn through fetal circulation. This excess of sebum promotes the accumulation of dead cells that remain adherent to the skin.
Another factor involved is the presence of the Malassezia yeast, in particular the M. globosa and M. restricta species, detected in most cases. This microorganism feeds on sebum and leaves residues of unsaturated fatty acids, which can contribute to the appearance of cradle cap. However, Malassezia is also present in healthy subjects, also suggesting an individual predisposition.
Incidence
- Frequent in the first months of life.
- Peak of 70% around the third month and then the incidence decreases progressively during the first year.
- About 7% of children are affected at two years.
- Cradle cap is rare after the age of four.
Symptoms
What?
Reddened plaques covered with yellowish and greasy scales.
Where?
Areas rich in sebaceous glands.
Cradle cap does not cause itching or pain, and does not interfere with the sleep or feeding of the newborn. In some cases, there may be a familial predisposition to other atopic conditions such as dermatitis or asthma.
Clinical study on cradle cap
Rilastil Xerolact cleansing oil
Evaluation of the efficacy of Xerolact cleansing oil on cradle cap.
In vivo test
Protocol
20 newborns
(16 days – 3 years) who have cradle cap on the scalp.
28 days
Use the cleansing oil once a day for 28 consecutive days. Apply the product to wet skin, massaging gently and rinse. Evaluations after 28 days.
Results
-99%
cradle cap severity in 28 days (statistically significant).
90%
of subjects experienced complete recovery.
Conclusions
Based on the experimental conditions adopted, the daily use of the product RILASTIL® XEROLACT ANTI-IRRITATION PROTECTIVE CLEANSING OIL for 28 consecutive days and according to the normal methods of use on a sample of 20 infants suffering from cradle cap at the scalp level, resulted in a statistically significant reduction in the severity of cradle cap.
Rilastil Xerolact cleansing oil
Protective and anti-irritation
Very dry, irritated and atopic-prone skin.
Newborns-children-adults
It gently cleanses and gives comfort to the skin of the face and body. Thanks to the moisturizing-lipid-replenishing complex, it helps restore of the barrier function, putting moisture back to the skin. The product is formulated to reduce the risk of eye irritation. Physiological pH 5.5.
Safety test
Efficacy test
Novelty
Cradle cap is a very common childhood skin condition, with a peak incidence of 70% of newborns by 3 months of age.
Xerolact cleansing oil, thanks to its tested effectiveness on cradle cap, is the ideal product to reduce the severity of cradle cap and promote a complete recovery of the newborn’s skin barrier.
